Continuous improvement of FEV 1 in severe eosinophilic asthmatics on anti-interleukin-5 therapy.

Authors :: Michils A
Makhoul JP
Blekic N
Haccuria A
Perez-Bogerd S
Malinovschi A
Van Muylem A
Source :: Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2845-2847. Date of Electronic Publication: 2024 Apr 24.
Publication Year :: 2024

Subjects :: Humans
Forced Expiratory Volume
Treatment Outcome
Male
Female
Eosinophilia drug therapy
Eosinophils immunology
Eosinophils metabolism
Middle Aged
Adult
Severity of Illness Index
Asthma drug therapy
Asthma diagnosis
Interleukin-5 antagonists & inhibitors
Anti-Asthmatic Agents therapeutic use

Full Text Access

Tools